JMP Securities Downgrades Haemonetics (HAE) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $118.51 +2.02%
Rating Summary:
11 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
11 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
JMP Securities downgraded Haemonetics (NYSE: HAE) from Market Outperform to Market Perform and removed its price target (priro $45.00).
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $37.19 yesterday.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $37.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Raymond James Downgrades Old Republic International (ORI) to Outperform
- Stephens Downgrades Illumina (ILMN) to Equal Weight
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
